FENC (Fennec Pharmaceuticals) Net Interest Margin (Bank Only) %


FENC Fennec Pharmaceuticals Inc FENC
54 GF Score
Price $11.02
GF Value $9.94
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Fennec Pharmaceuticals Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FENC
54GF Score
Fennec Pharmaceuticals Inc FENC
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fennec Pharmaceuticals (FENC) Overvalued in 2026?

Based on GuruFocus' analysis, Fennec Pharmaceuticals stock appears to be overvalued. The current stock price of $11.02 is trading 10.9% above its estimated GF Value™ of $9.94. GuruFocus considers Fennec Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for FENC:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $9.94 vs. price of $11.02 (10.9% above fair value)
  • GF Score™: 54/100 with 2 warning signs

No single metric tells the full story. See the FENC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fennec Pharmaceuticals Business Description

Other Exchanges RV41:GermanyFRX:Canada
Address 68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
54GF Score

Get the complete analysis for FENC

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.02
Price
$9.94
GF Value